Macrogenics (MGNX) Payables (2012 - 2026)

Macrogenics (MGNX) has 15 years of Payables data on file, last reported at $4.3 million in Q1 2026.

• On a quarterly basis, Payables fell 35.21% year-over-year to $4.3 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 35.21% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, down 4.51% from the prior year.
• Payables for Q1 2026 stood at $4.3 million, down from $4.8 million in the prior quarter.
• Over the last five years, Payables for MGNX reached as high as $10.7 million in Q1 2024 and fell as low as $2.6 million in Q2 2022.
• Historically, Payables has averaged $5.1 million across 5 years, with a median of $4.8 million in 2025.
• Across the five-year window, Payables sank 73.43% in 2022 and surged 184.49% in 2024, its largest moves.
• Year by year, Payables stood at $4.9 million in 2022, then jumped by 31.52% to $6.4 million in 2023, then dropped by 22.19% to $5.0 million in 2024, then slipped by 4.51% to $4.8 million in 2025, then declined by 10.44% to $4.3 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $4.3 million in Q1 2026, $4.8 million in Q4 2025, and $5.9 million in Q3 2025.